Despite significant reduction in childhood mortality, infant–particularly neonatal–mortality continues to be unacceptably high. A substantial proportion of these deaths could be averted by vaccinating mothers during pregnancy (maternal immunization). However, in order to realize the full life-saving potential of maternal immunization, it is important to develop clear introduction and delivery strategies for maternal vaccines. This will necessitate close collaboration between maternal health and immunization stakeholders. This article examines key considerations and areas for action to support successful and sustainable introduction and scale-up of maternal immunization, from the perspective of maternal, newborn, child, and adolescent health stakeholders.
CITATION STYLE
Khan, S., Fleming, J. A., & Engmann, C. M. (2022). Maternal vaccines: ten considerations for vaccine introduction and scale-up in low- and middle-income countries from the maternal, newborn, child, and adolescent health perspective. Human Vaccines and Immunotherapeutics. Taylor and Francis Ltd. https://doi.org/10.1080/21645515.2020.1865047
Mendeley helps you to discover research relevant for your work.